TimeScale Financial’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$5.65K	Hold	3,920	–	–	﹤0.01%	417
2023 Q1	$8.23K	Hold	3,920	–	–	﹤0.01%	369
2022 Q4	$6.39K	Hold	3,920	–	–	﹤0.01%	357
2022 Q3	$6K	Buy	+3,920	New	+$6K	﹤0.01%	363